Multiple-type meningitis pathogen nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device ID
- 125223
- MHRA Reference Number
- 125223
- Date Registered
- Nov 26, 2024
- Last Updated
- Nov 12, 2024
- Device Type
- In Vitro Diagnostic Device
- Devices
- Multiple-type meningitis pathogen nucleic acid IVD, kit, nucleic acid technique (NAT)
- Type
- IVD General
- Name
- Seegene Inc.
- Address
- Taewon Bldg., 91, Ogeum-ro, Songpa-gu Seoul, South Korea
- Created Date
- Aug 5, 2021
- Relationship Type
- UK Responsible Person
- Address
- Beaver House, 23-38 Hythe Bridge Street Oxford, England, United KingdomPostcode: OX1 2EP
Devices with a matching generic name or device type registered with MHRA
Additional devices registered by the same manufacturer
Additional devices represented by MT Promedt Consulting Ltd in the UK
Multiple-type meningitis pathogen nucleic acid IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 125223. The device is manufactured by Seegene Inc. from South Korea, classified as In Vitro Diagnostic Device. The authorized representative in the UK is MT Promedt Consulting Ltd.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.